Claris Lifesciences Ltd IPO : Fitch gives 3 out of 5

by khalid on 25/11/2010 · 0 comments

Claris Lifesciences Limited (CLL) IPO has got 3 out of 5 by Fitch (rating agency) and this rating/grading is Average for a sterile injectables pharmaceutical company. The grade 3 indicates that the fundamentals of the IPO are Average compared to the other listed securities in India. The company is entering into primary market with an Initial Public Offer (IPO) of 8848921 Equity Shares of Rs 10 each. The IPO is opening on 24th Nov 2010 and the shares will be available for subscription up to 26th Nov 2010. The premium of the issue will be decided through a 100% Book Building Process. The price band for the issue has been fixed at Rs. 278 – Rs. 293 Per Equity Share. Claris Lifesciences is one of the largest sterile injectables pharmaceutical companies in India with a market presence in 76 countries worldwide. The company’s products range across various therapeutic segments, including anaesthesia, critical care, anti-infectives, renal care, infusion therapy, enteral & parenteral nutrition and oncology.

Issue Detail:-
Issue Open : 24th Nov 2010 – 26th Nov 2010
Issue Type : 100% Book Built Issue IPO
Issue Size : 8848921 Equity Shares of Rs 10 each
Issue Size : Rs. 300 Crores
Face Value : Rs 10 Per Equity Share
Issue Price : Rs. 278 – Rs. 293 Per Equity Share
Minimum Bid Quantity : 22 Shares (Rs. 6446 with 1 Lot)
Maximum Bid Quantity : 682 Shares (Rs. 199826 with 31 Lot)
Listing At : BSE, NSE

Maximum Subscription Amount for Retail Investor : Rs. 200000

The Book running lead managers to the issue are Edelweiss Capital Ltd, Enam Securities Pvt Ltd, ICICI Securities Ltd and JM Financial Consultants Pvt Ltd.

Registrar of the Issue : Link Intime India Pvt Ltd .

Stay tuned to BelltheBull Blog for more on Claris Lifesciences Ltd IPO !

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: